Effect of Soluble HLA Class I Molecule on NK/LAK Cells Activation Induced by Poly I:C
نویسندگان
چکیده مقاله:
Background: Natural Killer cells express killer inhibitory receptors specific for HLA-class I molecules. These receptors could induce signals that determine NK cells ability to mediate cytotoxicity. Purified soluble form of HLA class I molecules (sHLA) could bind to NK cell receptors and down-regulate the NK killer function. Objective: To evaluate the influence of sHLA and two monoclonal antibodies (mAbs) against killer inhibitory receptors on the poly I:C-treated freshly and IL-2 activated NK cells (LAK cells).Methods: Isolation of CD56+ NK cells and CD56– cells was performed using the magnetic cell separation technique. CD56+ cells were activated by rIL-2 and anti-HLA-B7 specific cytotoxic T lymphocytes (CTLs) were established from CD56- cells. Flow cytometry analysis was performed to determine the percentage of CD3, CD16/CD56 and CD8 positive cells. LAK and specific CTLs were tested for cytotoxicity against M4 cells using the 51Cr-release assay. Freshly isolated NK cells and LAK cells were pre-incubated with 0.7-11 µg/ml of sHLA-B7 fused to the Fc portion of IgG molecule and subsequently tested for killing activity. The influence of the sHLA molecule on the cytotoxicity of the cells after treatment with poly I:C as an inducer of interferon was also studied. LAK cells were pre-treated with 0.01 to 10 µg/ml of two mAbs against NK inhibitory receptors, NKB1 and NKAT2. The effect of these mAbs on the killing activity of poly I:C and non-poly I:C treated LAK cells against K562 target cell was determined. Results: In flow cytometry analysis of LAK cells, 99.5% were found to be CD56+. Analysis of generated CTLs showed 88.4 % positivity for CD8. Cytotoxicity of M4 stimulated CTLs was 12.3% at 1.5/1 E/T ratio to 97.1% at 25/1 E/T ratio. NK cells had no effect on M4 cells. Anti-NKB1 and Anti-NKAT2 mAbs decreased the cytotoxic activity of LAK cells. These mAbs showed no effect on the poly I:C activated LAK cells. Increasing concentrations of sHLA molecule decreased cytotoxic activity of LAK cells from 17.2% to 13.8% and poly I:C activated NK cells from 62.5% to 51.8%. Treatment of LAK cells with poly I:C and exposure of these cells with increasing concentrations of sHLA resulted in an increase in the target cell killing of LAK cells from 20.1% to 27.6%.Conclusion: LAK cells were not able to kill M4 cells with high expression of HLA molecules, whereas CTLs were efficient in killing these cells. Recombinant sHLA fusion protein inhibited NK/LAK activity against K562 cells, whereas poly I:C activation of LAK cells reverted this effect indicating that poly I:C treatment of LAK cells could change the expression of NK inhibitory receptors.
منابع مشابه
Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule
The major histocompatibility complex class I HLA molecules are the primary determinants recognized by allogeneic cytotoxic T lymphocytes (CTL), and serve as restricting elements for CTL recognition of viral, chemical, or minor histocompatibility antigens. HLA-Aw69 is a naturally occurring hybrid class I molecule that we have used to investigate the regions of class I antigens involved in human ...
متن کاملthe effect of aqueous extract of garlic on formalin-induced pain in male rats
چکیده اثر عصاره آبی سیر بر درد ناشی از آزمون فرمالین در موش صحرایی نر به کوشش نرگس اسکندری روزبهانی زمینه و هدف: گیاه سیر از خانواده لیلیاسه و گونهallium sativum بومی آسیای میانه بوده و از دوران ،باستان تاکنون به خواص درمانی متفاوت آن مثل: کاهندگی قندخون، کلسترول خون، فشار خون، اثرات مفیدآن بر دستگاه قلبی عروقی و بیماریهای انعقادی خون، اثرات آنتی اکسیداتیو، درمان بیماریهای تنفسی وگوارشی، ا...
15 صفحه اولSpecific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
The CD94/NKG2 receptors expressed by subpopulations of NK cells and T cells have been implicated as receptors for a broad range of both classical and nonclassical HLA class I molecules. To examine the ligand specificity of CD94/NKG2 proteins, a soluble heterodimeric form of the receptor was produced and used in direct binding studies with cells expressing defined HLA class I/peptide complexes. ...
متن کاملCytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Human leukocytes were stimulated in vitro with peptides corresponding in sequence to the highly variable helix of the alpha 1 domain of various HLA-B and -C molecules. A CD4+ CD8- cytotoxic T cell line, CTL-AV, that is specific for the HLA-B7 peptide presented by HLA-DR11.1 was obtained. The HLA-DR11.2 molecule, which only differs at three residues from HLA-DR11.1, did not present the HLA-B7 pe...
متن کاملStable Down-Regulation of HLA Class-I by Serum Starvation in Human PBMCs
Background: The human leukocyte antigen (HLA) matching between organ donor and recipient is an acceptable strategy in clinical transplantation since 1964. However, in bone marrow transplantation, finding matched donors is often problematic. Thus new method for down regulation of HLA can be an alternative strategy to solve this problem. Objective: To examine the effect of serum starvation on HLA...
متن کاملDecreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies.
1 Super M, Gillies SD, Foley S, Sastry K, Schweinle JE, Silverman VJ, et al. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet 1992;2:50–5. 2 Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991;337:1569–70. 3 Garred P, Larsen F, Madsen HO, Koch C. Mannose-bind...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ذخیره در منابع من قبلا به منابع من ذحیره شده{@ msg_add @}
عنوان ژورنال
دوره 26 شماره 3-4
صفحات 102- 109
تاریخ انتشار 2001-12-01
با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023